News

Salesforce drives growth with AI-powered Agentforce, expanding margins and CRM leadership. Read more on CRM stock and its buy ...
This analysis is based on information available up to January 30, 2025, and reflects the views and projections of various analysts and financial institutions regarding Salesforce's stock ...
Salesforce is scheduled to report fiscal first-quarter results after the closing bell Wednesday, with analysts largely ...
Currently trading at a P/E ratio of 40.02, Salesforce commands a premium valuation that reflects its market leadership. Based on InvestingPro’s comprehensive Fair Value analysis, the stock ...
On June 9, an analyst at Oppenheimer reiterated his Outperform rating on the stock ... and analysis on the latest market action, check out more Asking for a Trend here. Will Salesforce Retaliate ...
Our dashboard – How Low Can Salesforce Stock Go In A Market Crash? – has a detailed analysis of how the stock performed during and after previous market crashes. Overall, Salesforce stock ...
After gaining over 25% in the past six months, I believe now is the time to sell Salesforce, Inc. (NYSE:CRM) stock. In the below technical analysis, I determine that charts, moving averages ...
This was the stock's second consecutive day of losses.
(To track post-earnings trends on the Street for Salesforce, such as sales and earnings revisions, head to the 'analysis' section on Yahoo Finance.) "Management talked about accelerating “growth ...
To watch more expert insights and analysis on the ... Now, taking a look at Salesforce as its first quarter results just hitting the wire right now. You can see that stock popping as these ...
While CNBC's Jim Cramer on Tuesday affirmed his confidence in Salesforce 's business and management, he detailed what's been weighing on the stock — namely worries that the cloud software outfit's ...
Currently trading at a P/E ratio of 40.02, Salesforce commands a premium valuation that reflects its market leadership. Based on InvestingPro’s comprehensive Fair Value analysis, the stock appears to ...